Importantly, while all WapCreC;Brca1;p53 double-mutant females developed mammary carcinomas, 25% of WapCreC;Rank;Brca1;p53 triple-mutant littermates never developed any tumors (Figure 2A). This evidence concerns the gene TP53 and breast carcinoma.